On this page
Lenskart Q1 FY27 profit rises 182% to Rs 228 crore as revenue grows 34%
Our read
Lenskart’s 30.7% India growth, expanding store network and Hyderabad capacity investment signal continued demand momentum but require disciplined execution to sustain higher margins.
Watch
EBITDA margin durability after capex-related depreciation, new-store costs, and international investment.
Ask next
The report,
Lenskart reported Q1 FY27 PAT of Rs 228 crore, up 182.3%, on 33.6% revenue growth to Rs 2,714 crore. India revenue rose 30.7%. It invested in stores and Hyderabad capacity while considering Framekart stake expansion and Korea and China subsidiaries.
Reported figures
From the report. Source details below
| EBITDA Rs 589 crore, up | 61.3% YoY |
|---|---|
| India revenue up 30.7% YoY; international revenue up | 38% |
| Consolidated product margin 70.3%, versus | 68.7% |
| Pre-IndAS 116 EBITDA margin 13.3%, versus | 9.1% |
| Overall EBITDA margin 21.7%, versus | 18.0% |
| PAT margin 8.4%, versus | 4.0% |
| Operating cash flow Rs 297 crore; capex | Rs 207 crore |
| Store capex Rs 75 crore; Hyderabad plant-capacity capex | Rs 132 crore |
| FY26 PAT about | Rs 530 crore |
Also in the report
- ROCE 23.2%, versus 14.6% in FY26
Why it matters to operators
International sales growth of 38% and Rs 207 crore in capacity and store capex make Lenskart a more credible platform for cross-border expansion, partnerships and selective market-entry deals.
What to watch next
- Sequential same-store sales growth and whether India revenue continues to grow near or above 30%.
- Hyderabad plant commissioning timeline, utilization rates, and impact on inventory turns and gross margin.
- Store-opening pace versus capex intensity and payback periods for new locations.
- International revenue growth, losses or profitability by market, and currency effects.
- Signs of promotional escalation from Titan Eye+, Specsmakers, online marketplaces, or local optical chains.
Likely next moves
Our read of what comes next — analysis, not reported by the source.
- Accelerate store openings in underpenetrated Indian cities using the stronger EBITDA base to fund rollout.
- Increase Hyderabad plant utilization and localize more frames and lenses to protect gross margin and shorten replenishment cycles.
- Push international expansion where 38% sales growth validates the model, likely prioritizing markets with existing digital acquisition channels.
- Use improved profitability to deepen omnichannel offerings, including eye-test conversion, membership programs, and higher-margin lens upgrades.
The counter-case
The case against this reading — not reported by the source.
The 182% PAT increase may overstate the durability of the improvement because it comes off a low 4.0% margin base; sustaining an 8.4% net margin while continuing heavy store rollout, manufacturing expansion and international investment is materially harder. The Rs 207 crore quarterly capex could pressure free cash flow and raise depreciation, while a higher mix of owned manufacturing and overseas operations may introduce execution, inventory and working-capital risks. EBITDA-margin expansion to 21.7% is strong, but could face reversal if promotional intensity, lens/input costs, store staffing or customer-acquisition spending rise.